Agilinko Joshua, Kueh Tze Jun, Smart Louise, Shakeel Muhammad
Department of Otolaryngology-Head and Neck Surgery, Aberdeen Royal Infirmary, Aberdeen, UK.
Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, UK.
BMJ Case Rep. 2021 Jan 28;14(1):e238560. doi: 10.1136/bcr-2020-238560.
Primary thyroid squamous cell carcinoma (SCC) is a rare and highly aggressive cancer. Diagnostic work-up encompasses cervical ultrasonography, tissue biopsy and CT scan. Surgery, radiotherapy and chemotherapy are the available treatment modalities. With a mean survival rate of 7 months reported in the literature, our patient is alive 2 years after successful treatment of her advanced primary thyroid SCC with surgery and radiotherapy.
原发性甲状腺鳞状细胞癌（SCC）是一种罕见且侵袭性很强的癌症。诊断性检查包括颈部超声检查、组织活检和CT扫描。手术、放疗和化疗是现有的治疗方式。文献报道的平均生存率为7个月，而我们的患者在通过手术和放疗成功治疗晚期原发性甲状腺SCC后已存活2年。
